부산대학교 도서관

Rezelj, Veronica V; Levi, Laura I; Vignuzzi, Marco

In Current Opinion in Virology December 2018 33:74-80

Tica J; Scientific Affairs and Late Development, Janssen-Cilag GmbH, Neuss, Germany.; Rezelj VV; Biomarkers, Viral Vaccines, Janssen Vaccines and Prevention, Leiden, The Netherlands.; Baron B; Biostatistics - Vaccines, Janssen Vaccines and Prevention, Leiden, The Netherlands.; van Paassen V; Biostatistics - Vaccines, Janssen Vaccines and Prevention, Leiden, The Netherlands.; Zaidman J; CIPREC, Centro Medico Arenales, Caba, Argentina.; Fairlie L; Maternal and Child Health, Wits RHI Shandukani, Johannesburg, South Africa.; Scheper G; Vaccine Research, Janssen Vaccines and Prevention, Leiden, The Netherlands.; Le Gars M; Biomarkers, Viral Vaccines, Janssen Vaccines and Prevention, Leiden, The Netherlands.; Struyf F; Scientific Affairs and Late Development, Janssen Research and Development, Beerse, Belgium.; Douoguih M; Clinical Development and Medical Affairs, Janssen Vaccines and Prevention, Leiden, The Netherlands.; Ruiz-Guiñazú J; Crucell Integration, Janssen Research and Development, Beerse, Belgium.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

Aguilar G; Global Medical Affairs, Johnson & Johnson, Leiden, The Netherlands.; Tapia-Calle G; Biomarkers, Viral Vaccines, Johnson & Johnson, Leiden, The Netherlands.; Robinson C; Clinical Research, Johnson & Johnson, Beerse, Belgium.; Baron B; Biostatistics, Johnson & Johnson, Leiden, The Netherlands.; Lowson D; FSP, Biostatistics, Cytel Statistical Services & Software Ltd, London, UK.; Maximos B; Maximos OB/GYN, League City, TX, USA.; Rezelj VV; Biomarkers, Viral Vaccines, Johnson & Johnson, Leiden, The Netherlands.; de Groot AM; Clinical Immunology, Johnson & Johnson, Leiden, The Netherlands.; Bet N; Clinical Immunology, Johnson & Johnson, Leiden, The Netherlands.; van Paassen V; Biostatistics, Johnson & Johnson, Leiden, The Netherlands.; Le Gars M; Biomarkers, Viral Vaccines, Johnson & Johnson, Leiden, The Netherlands.; Struyf F; Scientific Affairs and Late Development, Johnson & Johnson, Beerse, Belgium.; Ruiz-Guiñazú J; Crucell Integration, Johnson & Johnson, Beerse, Belgium.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

Rezelj VV; Janssen Vaccines & Prevention, 2301 CN Leiden, The Netherlands.; Paddenburg F; Vimef Holding B.V., 3311 GE Dordrech, The Netherlands.; Diegbe ME; Janssen Vaccines & Prevention, 2301 CN Leiden, The Netherlands.; Nangosyah J; Cytel Global Headquarters, Cambridge, MA 02139, USA.; Reisinger EC; Rostock University Medical Center, 18057 Rostock, Germany.; Hu W; Cytel Global Headquarters, Cambridge, MA 02139, USA.; Truyers C; Janssen Research and Development, 2340 Beerse, Belgium.; Scheper G; Janssen Vaccines & Prevention, 2301 CN Leiden, The Netherlands.; Le Gars M; Janssen Vaccines & Prevention, 2301 CN Leiden, The Netherlands.; Hendriks J; Janssen Vaccines & Prevention, 2301 CN Leiden, The Netherlands.; Struyf F; Janssen Research and Development, 2340 Beerse, Belgium.; Douoguih M; Janssen Vaccines & Prevention, 2301 CN Leiden, The Netherlands.; Schuitemaker H; Janssen Vaccines & Prevention, 2301 CN Leiden, The Netherlands.; Ruiz-Guiñazú J; Janssen Research and Development, 2340 Beerse, Belgium.

Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE

Hertoghs N; Janssen Vaccines and Prevention, Leiden, the Netherlands. Electronic address: nhertogh@its.jnj.com.; Roels S; Janssen Research and Development, Beerse, Belgium.; Brückner M; Janssen Research and Development, Beerse, Belgium.; Sadoff J; Janssen Vaccines and Prevention, Leiden, the Netherlands.; Banbury BL; Adaptive Biotechnologies Corp, Seattle, WA, USA.; Akers NK; Adaptive Biotechnologies Corp, Seattle, WA, USA.; Howie B; Adaptive Biotechnologies Corp, Seattle, WA, USA.; Robins HS; Adaptive Biotechnologies Corp, Seattle, WA, USA.; van Roey GA; Janssen Vaccines and Prevention, Leiden, the Netherlands.; Tolboom JTBM; Janssen Vaccines and Prevention, Leiden, the Netherlands.; Rezelj VV; Janssen Vaccines and Prevention, Leiden, the Netherlands.; Hendriks J; Janssen Vaccines and Prevention, Leiden, the Netherlands.; Schuitemaker H; Janssen Vaccines and Prevention, Leiden, the Netherlands.; Stieh DJ; Janssen Vaccines and Prevention, Leiden, the Netherlands.; Le Gars M; Janssen Vaccines and Prevention, Leiden, the Netherlands.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

Haas KM; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; McGregor MJ; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Bouhaddou M; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Polacco BJ; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Kim EY; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.; Nguyen TT; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Newton BW; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Urbanowski M; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Kim H; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.; Williams MAP; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Rezelj VV; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France.; Hardy A; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France.; Fossati A; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Stevenson EJ; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Sukerman E; Division of Infectious Diseases, Oregon Health & Science University, Portland, OR, 97239, USA.; Kim T; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.; Penugonda S; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.; Moreno E; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Department of Infectious Diseases, Hospital Universitario Ramón y Cajal and IRYCIS, Madrid, Spain.; Centro de Investigación en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Braberg H; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Zhou Y; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Metreveli G; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Harjai B; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Tummino TA; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, 94158, USA.; Graduate Program in Pharmaceutical Sciences and Pharmacogenomics, University of California San Francisco, San Francisco, CA, 94158, USA.; Melnyk JE; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Soucheray M; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Batra J; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Pache L; Infectious and Inflammatory Disease Center, Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.; Martin-Sancho L; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Department of Infectious Disease, Imperial College London, London, SW7 2BX, UK.; Carlson-Stevermer J; Synthego Corporation, Redwood City, CA, 94063, USA.; Serotiny Inc., South San Francisco, CA, 94080, USA.; Jureka AS; Molecular Virology and Vaccine Team, Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization & Respiratory Diseases, Centers for Disease Control & Prevention, Atlanta, GA, 30333, USA.; General Dynamics Information Technology, Federal Civilian Division, Atlanta, GA, 30329, USA.; Basler CF; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Shokat KM; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, 20815, USA.; Shoichet BK; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, 94158, USA.; Shriver LP; Department of Chemistry, Washington University in St. Louis, St. Louis, MO, 63105, USA.; Center for Metabolomics and Isotope Tracing, Washington University in St. Louis, St. Louis, MO, 63105, USA.; Johnson JR; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Shaw ML; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Department of Medical Biosciences, University of the Western Cape, Bellville, 7535, Western Cape, South Africa.; Chanda SK; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Roden DM; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Carter TC; Center for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI, 54449, USA.; Kottyan LC; Center of Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, 45229, USA.; Chisholm RL; Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.; Pacheco JA; Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.; Smith ME; Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.; Schrodi SJ; Laboratory of Genetics, School of Medicine and Public Health, University of Wisconsin Madison, Madison, WI, 53706, USA.; Albrecht RA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Vignuzzi M; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France.; Zuliani-Alvarez L; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Swaney DL; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Eckhardt M; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Wolinsky SM; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.; White KM; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Hultquist JF; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA. judd.hultquist@northwestern.edu.; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA. judd.hultquist@northwestern.edu.; Center for Pathogen Genomics and Microbial Evolution, Northwestern University Havey Institute for Global Health, Chicago, IL, 60611, USA. judd.hultquist@northwestern.edu.; Kaake RM; J. David Gladstone Institutes, San Francisco, CA, 94158, USA. robyn.kaake@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA. robyn.kaake@ucsf.edu.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA. robyn.kaake@ucsf.edu.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA. robyn.kaake@ucsf.edu.; García-Sastre A; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA. adolfo.garcia-sastre@mssm.edu.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. adolfo.garcia-sastre@mssm.edu.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. adolfo.garcia-sastre@mssm.edu.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. adolfo.garcia-sastre@mssm.edu.; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. adolfo.garcia-sastre@mssm.edu.; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. adolfo.garcia-sastre@mssm.edu.; Krogan NJ; J. David Gladstone Institutes, San Francisco, CA, 94158, USA. nevan.krogan@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA. nevan.krogan@ucsf.edu.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA. nevan.krogan@ucsf.edu.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA. nevan.krogan@ucsf.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Abatematteo Francesca Serena; Delre Pietro; Mercurio Ivan; Rezelj Veronica V; Siliqi Dritan; Beaucourt Stephanie; Lattanzi Gianluca; Colabufo Nicola Antonio; Leopoldo Marcello; Saviano Michele; Vignuzzi Marco; Mangiatordi Giuseppe Felice; Abate Carmen

Sci Rep
Scientific reports (Nature Publishing Group) 13 (2023). doi:10.1038/s41598-023-39662-w
info:cnr-pdr/source/autori:Abatematteo, Francesca Serena; Delre, Pietro; Mercurio, Ivan; Rezelj, Veronica V.; Siliqi, Dritan; Beaucourt, Stephanie; Lattanzi, Gianluca; Colabufo, Nicola Antonio; Leopoldo, Marcello; Saviano, Michele; Vignuzzi, Marco; Mangiatordi, Giuseppe Felice; Abate, Carmen/titolo:A conformational rearrangement of the SARS-CoV-2 host protein sigma-1 is required for antiviral activity: insights from a combined in-silico%2Fin-vitro approach/doi:10.1038%2Fs41598-023-39662-w/rivista:Scientific reports (Nature Publishing Group)/anno:2023/pagina_da:/pagina_a:/intervallo_pagine:/volume:13
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)

Caillet-Saguy C; Institut Pasteur, Unité Récepteurs-Canaux, UMR CNRS 3571, Paris, France.; Durbesson F; AFMB, UMR CNRS 7257, Marseille, France.; Rezelj VV; Institut Pasteur, Unité Populations Virales et Pathogénèse, UMR CNRS 3569, Paris, France.; Gogl G; IGBMC, INSERM U1258/UMR CNRS 7104, Illkirch, France.; Tran QD; Institut Pasteur, Unité Populations Virales et Pathogénèse, UMR CNRS 3569, Paris, France.; École doctorale BioSPC, Université Paris Diderot, Sorbonne Paris Cité, France.; Twizere JC; GIGA Institute, Molecular Biology of Diseases, Viral Interactomes laboratory, University of Liege, Belgium.; Vignuzzi M; Institut Pasteur, Unité Populations Virales et Pathogénèse, UMR CNRS 3569, Paris, France.; Vincentelli R; AFMB, UMR CNRS 7257, Marseille, France.; Wolff N; Institut Pasteur, Unité Récepteurs-Canaux, UMR CNRS 3571, Paris, France.

Publisher: Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies Country of Publication: England NLM ID: 101229646 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-4658 (Electronic) Linking ISSN: 1742464X NLM ISO Abbreviation: FEBS J Subsets: MEDLINE

Tummino TA; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.; Graduate Program in Pharmaceutical Sciences and Pharmacogenomics, UCSF, San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Rezelj VV; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; Fischer B; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.; Fischer A; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.; O'Meara MJ; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.; Monel B; Institut Pasteur, Virus and Immunity Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; Vallet T; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; White KM; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Zhang Z; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA, USA.; Howard Hughes Medical Institute, UCSF, San Francisco, CA, USA.; Alon A; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Schadt H; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.; O'Donnell HR; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.; Lyu J; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Rosales R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; McGovern BL; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Rathnasinghe R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Jangra S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Schotsaert M; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Galarneau JR; Novartis Institutes for BioMedical Research, Preclinical Safety, Cambridge, MA, USA.; Krogan NJ; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA, USA.; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, CA, USA.; Urban L; Novartis Institutes for BioMedical Research, Preclinical Safety, Cambridge, MA, USA.; Shokat KM; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA, USA.; Howard Hughes Medical Institute, UCSF, San Francisco, CA, USA.; Kruse AC; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Schwartz O; Institut Pasteur, Virus and Immunity Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; Moretti F; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland. bshoichet@gmail.com francois.pognan@novartis.com marco.vignuzzi@pasteur.fr francesca.moretti@novartis.com.; Vignuzzi M; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France. bshoichet@gmail.com francois.pognan@novartis.com marco.vignuzzi@pasteur.fr francesca.moretti@novartis.com.; Pognan F; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland. bshoichet@gmail.com francois.pognan@novartis.com marco.vignuzzi@pasteur.fr francesca.moretti@novartis.com.; Shoichet BK; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA. bshoichet@gmail.com francois.pognan@novartis.com marco.vignuzzi@pasteur.fr francesca.moretti@novartis.com.; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Rezelj VV; Institut Pasteur, Viral Populations and Pathogenesis Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Carrau L; Institut Pasteur, Viral Populations and Pathogenesis Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Merwaiss F; Institut Pasteur, Viruses and RNA Interference Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Levi LI; Institut Pasteur, Viral Populations and Pathogenesis Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; École doctorale BioSPC, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.; Erazo D; Institut Pasteur, Viral Populations and Pathogenesis Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Tran QD; Institut Pasteur, Viral Populations and Pathogenesis Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; École doctorale BioSPC, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.; Henrion-Lacritick A; Institut Pasteur, Viruses and RNA Interference Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Gausson V; Institut Pasteur, Viruses and RNA Interference Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Suzuki Y; Institut Pasteur, Viruses and RNA Interference Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Shengjuler D; Institut Pasteur, Viral Populations and Pathogenesis Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Meyer B; Institut Pasteur, Viral Populations and Pathogenesis Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Vallet T; Institut Pasteur, Viral Populations and Pathogenesis Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Weger-Lucarelli J; Institut Pasteur, Viral Populations and Pathogenesis Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Bernhauerová V; Institut Pasteur, Viral Populations and Pathogenesis Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Titievsky A; Tauber Bioinformatics Research Center, University of Haifa, Haifa, Israel.; Sharov V; Tauber Bioinformatics Research Center, University of Haifa, Haifa, Israel.; Pietropaoli S; Institut Pasteur, Unité de Virologie Structurale, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Diaz-Salinas MA; Institut Pasteur, Unité de Recherche et d'Expertise Environnement et Risques Infectieux, Groupe Arbovirus, Paris, Cedex 15, France.; Legros V; Institut Pasteur, Unité de Virologie Structurale, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Pardigon N; Institut Pasteur, Unité de Recherche et d'Expertise Environnement et Risques Infectieux, Groupe Arbovirus, Paris, Cedex 15, France.; Barba-Spaeth G; Institut Pasteur, Unité de Virologie Structurale, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Brodsky L; Tauber Bioinformatics Research Center, University of Haifa, Haifa, Israel.; Saleh MC; Institut Pasteur, Viruses and RNA Interference Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France. carla.saleh@pasteur.fr.; Vignuzzi M; Institut Pasteur, Viral Populations and Pathogenesis Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France. marco.vignuzzi@pasteur.fr.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Levi LI; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France.; École doctorale BioSPC, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.; Rezelj VV; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France.; Henrion-Lacritick A; Institut Pasteur, Viruses and RNAi Unit, CNRS UMR 3569, Paris, France.; Erazo D; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France.; Boussier J; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France.; École doctorale Frontières du vivant, Université Paris Diderot, Paris, France.; Vallet T; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France.; Bernhauerová V; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France.; Department of Biophysics and Physical Chemistry, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic.; Suzuki Y; Institut Pasteur, Viruses and RNAi Unit, CNRS UMR 3569, Paris, France.; Carrau L; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France.; École doctorale BioSPC, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.; Weger-Lucarelli J; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France.; Department of Biomedical Sciences and Pathobiology, Virginia Tech, VA-MD Regional College of Veterinary Medicine, Blacksburg, Virginia, United States of America.; Saleh MC; Institut Pasteur, Viruses and RNAi Unit, CNRS UMR 3569, Paris, France.; Vignuzzi M; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE

David E. Gordon; Joseph Hiatt; Mehdi Bouhaddou; Veronica V. Rezelj; Svenja Ulferts; Hannes Braberg; Alexander S. Jureka; Kirsten Obernier; Jeffrey Z. Guo; Jyoti Batra; Robyn M. Kaake; Andrew R. Weckstein; Tristan W. Owens; Meghna Gupta; Sergei Pourmal; Erron W. Titus; Merve Cakir; Margaret Soucheray; Michael McGregor; Zeynep Cakir; Gwendolyn Jang; Matthew J. O’Meara; Tia A. Tummino; Ziyang Zhang; Helene Foussard; Ajda Rojc; Yuan Zhou; Dmitry Kuchenov; Ruth Hüttenhain; Jiewei Xu; Manon Eckhardt; Danielle L. Swaney; Jacqueline M. Fabius; Manisha Ummadi; Beril Tutuncuoglu; Ujjwal Rathore; Maya Modak; Paige Haas; Kelsey M. Haas; Zun Zar Chi Naing; Ernst H. Pulido; Ying Shi; Inigo Barrio-Hernandez; Danish Memon; Eirini Petsalaki; Alistair Dunham; Miguel Correa Marrero; David Burke; Cassandra Koh; Thomas Vallet; Jesus A. Silvas; Caleigh M. Azumaya; Christian Billesbølle; Axel F. Brilot; Melody G. Campbell; Amy Diallo; Miles Sasha Dickinson; Devan Diwanji; Nadia Herrera; Nick Hoppe; Huong T. Kratochvil; Yanxin Liu; Gregory E. Merz; Michelle Moritz; Henry C. Nguyen; Carlos Nowotny; Cristina Puchades; Alexandrea N. Rizo; Ursula Schulze-Gahmen; Amber M. Smith; Ming Sun; Iris D. Young; Jianhua Zhao; Daniel Asarnow; Justin Biel; Alisa Bowen; Julian R. Braxton; Jen Chen; Cynthia M. Chio; Un Seng Chio; Ishan Deshpande; Loan Doan; Bryan Faust; Sebastian Flores; Mingliang Jin; Kate Kim; Victor L. Lam; Fei Li; Junrui Li; Yen-Li Li; Yang Li; Xi Liu; Megan Lo; Kyle E. Lopez; Arthur A. Melo; Frank R. Moss; Phuong Nguyen; Joana Paulino; Komal Ishwar Pawar; Jessica K. Peters; Thomas H. Pospiech; Maliheh Safari; Smriti Sangwan; Kaitlin Schaefer; Paul V. Thomas; Aye C. Thwin; Raphael Trenker; Eric Tse; Tsz Kin Martin Tsui; Feng Wang; Natalie Whitis; Zanlin Yu; Kaihua Zhang; Yang Zhang; Fengbo Zhou; Daniel Saltzberg; Anthony J. Hodder; Amber S. Shun-Shion; Daniel M. Williams; Kris M. White; Romel Rosales; Thomas Kehrer; Lisa Miorin; Elena Moreno; Arvind H. Patel; Suzannah Rihn; Mir M. Khalid; Albert Vallejo-Gracia; Parinaz Fozouni; Camille R. Simoneau; Theodore L. Roth; David Wu; Mohd Anisul Karim; Maya Ghoussaini; Ian Dunham; Francesco Berardi; Sebastian Weigang; Maxime Chazal; Jisoo Park; James Logue; Marisa McGrath; Stuart Weston; Robert Haupt; C. James Hastie; Matthew Elliott; Fiona Brown; Kerry A. Burness; Elaine Reid; Mark Dorward; Clare Johnson; Stuart G. Wilkinson; Anna Geyer; Daniel M. Giesel; Carla Baillie; Samantha Raggett; Hannah Leech; Rachel Toth; Nicola Goodman; Kathleen C. Keough; Abigail L. Lind; Reyna J. Klesh; Kafi R. Hemphill; Jared Carlson-Stevermer; Jennifer Oki; Kevin Holden; Travis Maures; Katherine S. Pollard; Andrej Sali; David A. Agard; Yifan Cheng; James S. Fraser; Adam Frost; Natalia Jura; Tanja Kortemme; Aashish Manglik; Daniel R. Southworth; Robert M. Stroud; Dario R. Alessi; Paul Davies; Matthew B. Frieman; Trey Ideker; Carmen Abate; Nolwenn Jouvenet; Georg Kochs; Brian Shoichet; Melanie Ott; Massimo Palmarini; Kevan M. Shokat; Adolfo García-Sastre; Jeremy A. Rassen; Robert Grosse; Oren S. Rosenberg; Kliment A. Verba; Christopher F. Basler; Marco Vignuzzi; Andrew A. Peden; Pedro Beltrao; Nevan J. Krogan; Donovan Trinidad; Joana Damas; Graham M. Hughes; Corrie A. Painter; Nicole S. Persky; Marco Corbo; Bodgan Kirilenko; Michael Hiller; Klaus-Peter Koepfli; Irene Kaplow; Morgan Wirthlin; Andreas R. Pfenning; Huabin Zhao; Diane P. Genereux; Ross Swofford; Abigail Lind; Oliver A. Ryderq; Martin T. Nweeia; Jennifer Meadows; Michael Dong; Ola Wallerman; Vikki Marinescu; Kerstin Lindblad-Toh; David A. Ray; Sarahjane Power; Emma C. Teeling; Gaurav Chauhan; Shirley Xue Li; Elinor K. Karlsson; Harris A. Lewin

Science
Science, vol 370, iss 6521

Gordon, David E; Jang, Gwendolyn M; Bouhaddou, Mehdi; Xu, Jiewei; Obernier, Kirsten; White, Kris M; O'Meara, Matthew J; Rezelj, Veronica V; Guo, Jeffrey Z; Swaney, Danielle L; Tummino, Tia A; Hüttenhain, Ruth; Kaake, Robyn M; Richards, Alicia L; Tutuncuoglu, Beril; Foussard, Helene; Batra, Jyoti; Haas, Kelsey; Modak, Maya; Kim, Minkyu; Haas, Paige; Polacco, Benjamin J; Braberg, Hannes; Fabius, Jacqueline M; Eckhardt, Manon; Soucheray, Margaret; Bennett, Melanie J; Cakir, Merve; McGregor, Michael J; Li, Qiongyu; et al

Rezelj, Veronica V; Överby, Anna K, 1978; Elliott, Richard M

Journal of Virology. 89(9):4849-4856

Samelson AJ; Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA.; Chan-Zuckerberg Biohub, San Francisco, CA, USA.; Tran QD; Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France.; École Doctorale BioSPC, Université de Paris, Sorbonne Paris Cité, Paris, France.; Robinot R; Institut Pasteur, CIVIC Group, Virus and Immunity Unit, Université de Paris, Paris, France.; Carrau L; Microbiology Department, NYU-Langone, New York, NY, USA.; Rezelj VV; Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France.; Kain AM; Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France.; École Doctorale BioSPC, Université de Paris, Sorbonne Paris Cité, Paris, France.; Chen M; Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA.; Chan-Zuckerberg Biohub, San Francisco, CA, USA.; Ramadoss GN; Gladstone Institutes, San Francisco, CA, USA.; Biomedical Sciences PhD Program, University of California San Francisco, San Francisco, CA, USA.; Guo X; Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA.; Chan-Zuckerberg Biohub, San Francisco, CA, USA.; Lim SA; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Department of Antibody Engineering, Genentech Inc., San Francisco, CA, USA.; Lui I; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Nuñez JK; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA.; Rockwood SJ; Gladstone Institutes, San Francisco, CA, USA.; Wang J; School of Medicine, Southern University of Science and Technology, Shenzhen, China.; Liu N; School of Medicine, Southern University of Science and Technology, Shenzhen, China.; Carlson-Stevermer J; Synthego Corporation, Redwood City, CA, USA.; Oki J; Synthego Corporation, Redwood City, CA, USA.; Maures T; Synthego Corporation, Redwood City, CA, USA.; Holden K; Synthego Corporation, Redwood City, CA, USA.; Weissman JS; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA.; Whitehead Institute for Biomedical Research, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, USA.; Wells JA; Chan-Zuckerberg Biohub, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Conklin BR; Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; TenOever BR; Microbiology Department, NYU-Langone, New York, NY, USA.; Chakrabarti LA; Institut Pasteur, CIVIC Group, Virus and Immunity Unit, Université de Paris, Paris, France.; Vignuzzi M; Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France.; Tian R; Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA. tianrl@sustech.edu.cn.; Chan-Zuckerberg Biohub, San Francisco, CA, USA. tianrl@sustech.edu.cn.; School of Medicine, Southern University of Science and Technology, Shenzhen, China. tianrl@sustech.edu.cn.; Kampmann M; Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA. martin.kampmann@ucsf.edu.; Chan-Zuckerberg Biohub, San Francisco, CA, USA. martin.kampmann@ucsf.edu.; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA. martin.kampmann@ucsf.edu.

Publisher: Macmillan Magazines Ltd Country of Publication: England NLM ID: 100890575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4679 (Electronic) Linking ISSN: 14657392 NLM ISO Abbreviation: Nat Cell Biol Subsets: MEDLINE

Bernhauerová V; Department of Biophysics and Physical Chemistry, Faculty of Pharmacy, Charles University, Heyrovského 1203, Hradec Králové 500 05, Czech Republic. Electronic address: bernhauve@faf.cuni.cz.; Lisowski B; Department of Biophysics, Chair of Physiology, Jagiellonian University Medical College, św. Łazarza 16, Kraków 31-530, Poland.; Rezelj VV; Institut Pasteur, Viral Populations and Pathogenesis Unit, Department of Virology, CNRS UMR 3569, Paris F-75015, France.; Vignuzzi M; Institut Pasteur, Viral Populations and Pathogenesis Unit, Department of Virology, CNRS UMR 3569, Paris F-75015, France. Electronic address: marco.vignuzzi@pasteur.fr.

Publisher: Elsevier Country of Publication: England NLM ID: 0376342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-8541 (Electronic) Linking ISSN: 00225193 NLM ISO Abbreviation: J Theor Biol Subsets: MEDLINE

Sharov V; Tauber Bioinformatics Research Center, University of Haifa, Haifa, Israel.; Laboratory of Genomic Research and Biotechnology, Federal Research Center Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences, Krasnoyarsk, Russian Federation.; Rezelj VV; Institut Pasteurgrid.428999.7, Viral Populations and Pathogenesis Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Galatenko VV; Tauber Bioinformatics Research Center, University of Haifa, Haifa, Israel.; Titievsky A; Tauber Bioinformatics Research Center, University of Haifa, Haifa, Israel.; Panov J; Tauber Bioinformatics Research Center, University of Haifa, Haifa, Israel.; Sagol Department of Neurobiology, University of Haifa, Haifa, Israel.; Chumakov K; Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.; Global Virus Network, Baltimore, Maryland, USA.; Andino R; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA.; Vignuzzi M; Institut Pasteurgrid.428999.7, Viral Populations and Pathogenesis Unit, Centre National de la Recherche Scientifique UMR 3569, Paris, France.; Brodsky L; Tauber Bioinformatics Research Center, University of Haifa, Haifa, Israel.

Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE

Samelson AJ; Institute for Neurodegenerative Diseases, Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94158, USA.; Chan-Zuckerberg Biohub, San Francisco, CA 94158, USA.; Tran QD; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75015 Paris, France.; École Doctorale BioSPC, Université de Paris, Sorbonne Paris Cité, 75006 Paris, France.; Robinot R; Institut Pasteur, CIVIC Group, Virus and Immunity Unit, CNRS UMR 3569, 75015 Paris, France.; Carrau L; Department of Microbiology, Icahn School of Medicine, New York, NY 10029.; Rezelj VV; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75015 Paris, France.; Mac Kain A; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75015 Paris, France.; École Doctorale BioSPC, Université de Paris, Sorbonne Paris Cité, 75006 Paris, France.; Chen M; Institute for Neurodegenerative Diseases, Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94158, USA.; Chan-Zuckerberg Biohub, San Francisco, CA 94158, USA.; Ramadoss GN; Gladstone Institutes, San Francisco, 94158, CA, USA.; Biomedical Sciences PhD Program, University of California, San Francisco, CA, USA.; Guo X; Institute for Neurodegenerative Diseases, Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94158, USA.; Chan-Zuckerberg Biohub, San Francisco, CA 94158, USA.; Lim SA; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, 94158, USA.; Present address: Department of Antibody Engineering, Genentech Inc., South San Francisco, CA, 94080, USA.; Lui I; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, 94158, USA.; Nunez J; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; Howard Hughes Medical Institute, University of California, San Francisco, CA 94158, USA.; Rockwood SJ; Gladstone Institutes, San Francisco, 94158, CA, USA.; Wang J; School of Medicine, Southern University of Science and Technology, Shenzhen, China 518055.; Liu N; School of Medicine, Southern University of Science and Technology, Shenzhen, China 518055.; Carlson-Stevermer J; Synthego Corporation, Redwood City, CA 94063, USA, Department of Biology, Massachusetts Institute of Technology, Cambridge, 02142, USA.; Oki J; Synthego Corporation, Redwood City, CA 94063, USA, Department of Biology, Massachusetts Institute of Technology, Cambridge, 02142, USA.; Maures T; Synthego Corporation, Redwood City, CA 94063, USA, Department of Biology, Massachusetts Institute of Technology, Cambridge, 02142, USA.; Holden K; Synthego Corporation, Redwood City, CA 94063, USA, Department of Biology, Massachusetts Institute of Technology, Cambridge, 02142, USA.; Weissman JS; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; Howard Hughes Medical Institute, University of California, San Francisco, CA 94158, USA.; Whitehead Institute for Biomedical Research, Cambridge, 02142, USA, Innovative Genomics Institute, Berkeley, 94720, CA, USA.; Wells JA; Chan-Zuckerberg Biohub, San Francisco, CA 94158, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; Conklin BR; Gladstone Institutes, San Francisco, 94158, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; Department of Ophthalmology, University of California, San Francisco, San Francisco, CA. 94158, USA.; Department of Medicine, University of California, San Francisco, San Francisco, CA, 94158, USA.; TenOever BR; Department of Microbiology, Icahn School of Medicine, New York, NY 10029.; Chakrabarti LA; Institut Pasteur, CIVIC Group, Virus and Immunity Unit, CNRS UMR 3569, 75015 Paris, France.; Vignuzzi M; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75015 Paris, France.; Tian R; Institute for Neurodegenerative Diseases, Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94158, USA.; Chan-Zuckerberg Biohub, San Francisco, CA 94158, USA.; School of Medicine, Southern University of Science and Technology, Shenzhen, China 518055.; Kampmann M; Institute for Neurodegenerative Diseases, Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94158, USA.; Chan-Zuckerberg Biohub, San Francisco, CA 94158, USA.; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, 94158, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Tummino TA; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.; Graduate Program in Pharmaceutical Sciences and Pharmacogenomics, UCSF, San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Rezelj VV; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; Fischer B; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.; Fischer A; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.; O'Meara MJ; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.; Monel B; Institut Pasteur, Virus and Immunity Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; Vallet T; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; Zhang Z; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA, USA.; Howard Hughes Medical Institute, UCSF, San Francisco, CA, USA.; Alon A; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; O'Donnell HR; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.; Lyu J; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Schadt H; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.; White KM; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Krogan NJ; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA, USA.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, CA, USA.; Urban L; Novartis Institutes for BioMedical Research, Preclinical Safety, Cambridge, MA, USA.; Shokat KM; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA, USA.; Howard Hughes Medical Institute, UCSF, San Francisco, CA, USA.; Kruse AC; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Schwartz O; Institut Pasteur, Virus and Immunity Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; Moretti F; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.; Vignuzzi M; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; Pognan F; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.; Shoichet BK; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Donald CL; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.; Brennan B; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.; Cumberworth SL; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.; Rezelj VV; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.; Clark JJ; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.; Cordeiro MT; Fundação Oswaldo Cruz-PE/Centro de Pesquisas Aggeu Magalhães, Departamento de Virologia, Campus da UFPE-Cidade Universitária, Recife/PE, Brasil.; Freitas de Oliveira França R; Fundação Oswaldo Cruz-PE/Centro de Pesquisas Aggeu Magalhães, Departamento de Virologia, Campus da UFPE-Cidade Universitária, Recife/PE, Brasil.; Pena LJ; Fundação Oswaldo Cruz-PE/Centro de Pesquisas Aggeu Magalhães, Departamento de Virologia, Campus da UFPE-Cidade Universitária, Recife/PE, Brasil.; Wilkie GS; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.; Da Silva Filipe A; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.; Davis C; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.; Hughes J; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.; Varjak M; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.; Selinger M; Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.; Institute of Parasitology, Biology Centre of the Academy of Sciences of the Czech Republic, České Budějovice, Czech Republic.; Zuvanov L; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.; Owsianka AM; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.; Patel AH; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.; McLauchlan J; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.; Lindenbach BD; Department of Microbial Pathogenesis, Yale University, New Haven, Connecticut, United States of America.; Fall G; Pole de Virologie, Unité des arbovirus et virus des fièvres hémorragiques, Institut Pasteur de Dakar, Dakar, Senegal.; Sall AA; Pole de Virologie, Unité des arbovirus et virus des fièvres hémorragiques, Institut Pasteur de Dakar, Dakar, Senegal.; Biek R; Boyd Orr Centre for Population and Ecosystem Health, Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.; Rehwinkel J; Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine and Radcliffe Department of Medicine, University of Oxford, Oxford, England, United Kingdom.; Schnettler E; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.; Kohl A; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet ISSN: 1935-2735 (Electronic) Linking ISSN: 19352727 NLM ISO Abbreviation: PLoS Negl Trop Dis Subsets: MEDLINE